Short description
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Description
EyePoint Pharmaceuticals develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. The company have developed three approved products in either the U.S. or the EU for sustained release delivery of drug utilizing multiple generations of our Durasert technology system.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Watertown, Massachusetts, United States, North America
Founded on
January 1, 1987
Exited on
February 4, 2005
Went public on
February 4, 2005
Stock symbol
EYPT
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccess, Noaccessforu, Noaccessforu, Uh Ohhhh, Cannot Access
Sign in for full access